The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries

The global COVID-19 pandemic is still ongoing, and cross-country and cross-period variation in COVID-19 age-adjusted case fatality rates (CFRs) has not been clarified. Here, we aimed to identify the country-specific effects of booster vaccination and other features that may affect heterogeneity in a...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Frontiers in public health Ročník 11; s. 1150095
Hlavní autori:	Zhou, Cui, Wheelock, Åsa M., Zhang, Chutian, Ma, Jian, Dong, Kaixing, Pan, Jingxiang, Li, Zhichao, Liang, Wannian, Gao, Jing, Xu, Lei
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Frontiers Media S.A 2023
Predmet:	age-adjusted case fatality rate Cost of Illness COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control Humans Pandemics Public Health Risk Factors SHapley Additive exPlanations Vaccination XGBoost (Extreme Gradient Boosting) COVID-19 age-adjusted case fatality rate SHapley Additive exPlanations XGBoost (Extreme Gradient Boosting) vaccination
ISSN:	2296-2565, 2296-2565
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!